.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Mallinckrodt
Moodys
Chubb
UBS
Fuji
Merck
Harvard Business School
Teva
Julphar

Generated: December 15, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: crofelemer

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Napo Pharms IncFULYZAQcrofelemerTABLET, DELAYED RELEASE;ORAL202292NDANapo Pharmaceuticals, Inc.70564-802-6060 TABLET, COATED in 1 BOTTLE (70564-802-60)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Boehringer Ingelheim
Federal Trade Commission
Dow
Merck
McKesson
Mallinckrodt
Cipla
Cantor Fitzgerald
Argus Health

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot